Nathan Haas, MD
Associate Medical Director of Emergency Critical Care Center (EC3)
Clinical Assistant Professor of Emergency Medicine
Taubman Center B1-354-K 1500 E Medical Center Drive, SPC 5303
Ann Arbor
MI, 48109-5303 United States
[email protected]

Available to mentor
Nathan Haas, MD
Clinical Assistant Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
    • About

    I am a practicing Emergency Physician, and I work clinically in the Adult Emergency Department and the Emergency Critical Care Center (EC3), where I serve as Assistant Medical Director.

    Qualifications
    • Advanced Research Methodology Evaluation and Design (ARMED)
      Society for Academic Emergency Medicine (SAEM), United States, 2019
    • Emergency Medicine Residency
      University of Michigan, Ann Arbor, 2018
    • Chief Resident, Emergency Medicine
      University of Michigan, Ann Arbor, 2018
    • Healthcare Administration Scholars Program
      University of Michigan, Ann Arbor, 2018
    • Leadership Acadamy
      American Academy of Emergency Medicine, United States, 2017
    • Research Honors Program
      Loyola University Chicago Stritch School of Medicine, United States, 2014
    • Leadership in Medicine Program
      Loyola University Chicago Stritch School of Medicine, United States, 2014
    • MD
      Loyola University Chicago Stritch School of Medicine, Maywood, 2014
    • BS
      University of Illinois, Urbana-Champaign, 2009
    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    Research Overview

    My main research interests are the delivery of ED-based critical care, including assessing outcomes associated with our novel ED-ICU, management strategies for diabetic ketoacidosis (DKA), and out-of-hospital cardiac arrest.

    Recent Publications See All Publications
    • Presentation
      You've got this! Best practices in the care of critically ill boarding patients (Critical care interest group sponsored)
      2024 May 15;
    • Journal Article
      Age ain't nothing but a number.
      Haas NL, Tonna JE. Resuscitation, 2023 Dec; 193: 110047 DOI:10.1016/j.resuscitation.2023.110047
      PMID: 37977346
    • Additional Scholarship
      Inpatient Alcohol Withdrawal in Hospitalized Patients Guideline; University of Michigan
      Blackburn S, Haas N, Kocan MJ, Wood W, Menke N, Seyfried L, Chinn S, VandenBerg A, Ciarkowski S. 2023 Oct 24;
    • Presentation
      Glycemic variability following traumatic brain injury: utilizing a continuous glucose monitor in the golden hours to improve patient outcomes
      2023 Oct 19;
    • Journal Article
      Impact of emergency department-based intensive care unit on outcomes of decompensating boarding emergency department patients.
      Doan J, Perez S, Bassin BS, England P, Chen C-M, Cranford JA, Gottula AL, Hartley S, Haas NL. J Am Coll Emerg Physicians Open, 2023 Oct; 4 (5): e13036 DOI:10.1002/emp2.13036
      PMID: 37692194
    • Additional Scholarship
      Pharmacy Services Management of Diabetic Ketoacidosis (DKA) In Non- Pregnant Adults In the Emergency Department (ED) / Emergency Critical Care Center (EC3) and Critical Care Medical Unit (CCMU) Guideline
      Butler S. 2023 Sep 28;
    • Journal Article
      Euglycemic Diabetic Ketoacidosis: Experience with 44 Patients and Comparison to Hyperglycemic Diabetic Ketoacidosis
      Sell J, Haas N, Korley F, Cranford J, Bassin B. Western Journal of Emergency Medicine, 2023 Sep 25; 24 (6): 1049 - 1055. DOI:10.5811/westjem.60361
    • Journal Article
      Diabetic ketoacidosis as a complication of immune checkpoint inhibitor therapy
      Haas N, Sell J, Bassin B, Korley F. JEM Reports, 2023 Jun 1; 2 (2): DOI:10.1016/j.jemrpt.2023.100022
    Featured News & Stories drawing of blood monitor on person
    Health Lab
    Continuous glucose monitors can optimize diabetic ketoacidosis management
    University of Michigan researchers show that using continuous glucose monitors can help measure glucose accurately during DKA and potentially prevent ICUs from being overwhelmed.
         Illustration of the BioHelmet depicting clean air flowing in via the helmet's shroud and contaminated air flowing out through the attached HEPA filter and waist-mounted fan unit.
    Research News
    Weil Institute spin-off InspireRx awarded over $2 million for patient isolation system guarding against airborne infections
    InspireRx, LLC., a spin-off company of the University of Michigan (U-M) Max Harry Weil Institute for Critical Care Research and Innovation, received over $2 million in Small Business Innovation Research (SBIR) grants to support further development of the AerosolVE BioHelmet, a compact negative pressure system for patients with highly contagious airborne respiratory infections such as COVID-19.